Featured
Experts

B2i Digital's Featured Experts are industry experts vetted by B2i. They provide invaluable support to companies active in the markets. They work with both private and public companies and all key constituents in the capital markets. From legal and regulatory guidance to financial technology and corporate strategy, they provide valuable services to help businesses navigate complex challenges.

B2i Digital Featured Experts

Explore their profiles to see how these industry leaders help companies navigate the intricacies of the capital markets both in the US and globally.

 

A leading provider of financial printing, SEC filing, and corporate communication services, offering tailored solutions for public companies, investment banks, and law firms. 

Harter Secrest & Emery (HSE), founded in 1894, is a prominent full-service law firm with offices in Rochester, Buffalo, Albany, Corning, and New York City.

The company provides outsourced risk management solutions to the capital markets by managing operational risk, executive risk, and employee benefits.

The most versatile corporate and investor relations website solution on the market.

B2i Digital Featured Experts

Explore their profiles to see how these industry leaders help companies navigate the intricacies of the capital markets both in the US and globally.

 

HSE

eXoZymes (Nasdaq: EXOZ) has developed a biomanufacturing platform that - as a historic first - offers the tools and insights to design, engineer, control and optimize nature’s own natural processes to produce chemical compounds, enabling the company’s partners to upgrade traditional petro-chemical production methods with a new commercially scalable, sustainable, and eco-friendly alternative: exozymes. Exozymes are advanced enzymes enhanced through AI and bioengineering to thrive in a bioreactor without using living cells. Exozymes can replace toxic petrochemical processes and inefficient biochemical extraction with sustainable and scalable biosolutions that transform biomass into essential chemicals, medicines, and biofuels. By freeing enzyme-driven chemical reactions from the limitations imposed by cells, exozyme biosolutions eliminate the scaling bottleneck that has hampered commercial success in the synthetic biology (SynBio) space, making exozymes the next generation of biomanufacturing. While the company, eXoZymes Inc., has introduced “exozymes” as a scientific concept, they are not trademarking the concept, as they view it as a new nomenclature for wide adoption for this next generation of biomanufacturing that eXoZymes aims to pioneer and be the market leader of.

NSI-Insurance-Group-Logo-800-Unison-Risk

Focus Universal Inc. is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company had developed five disruptive patented technology platforms with 28 patents and patents pending in various phases and eight trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. As a process of maintenance without losing protection, the company is in the process of filing additional omnibus patents. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus currently trades on the Nasdaq Markets. 

B2i Logo

U.S. Antimony Corporation (NYSE Texas: UAMY) is the only antimony smelter in North America, playing a critical role in securing domestic supply of this federally designated strategic and critical mineral. Antimony is an essential component for military munitions, energy storage (lithium-ion & lead-acid batteries, solar panels), semiconductors, and fire-retardant materials. In addition to antimony, the company also owns and operates Bear River Zeolite, a high-purity natural zeolite mine used in environmental remediation, agriculture, animal feed, and sustainable construction. With operations headquartered in Dallas, TX, UAMY supports U.S. supply chain independence, national defense priorities, and green technology markets.

Explore b2i Digital

featured-conferences-badge

B2i Digital partners with prestigious conferences to bridge the online and offline worlds.

Browse Conferences
featured-companies-badge

Dig into each company's unique story, bios, and filed documents.

View Featured Companies
featured-experts-badge

Industry experts vetted by B2i, providing invaluable support to active market companies.

Meet Our Experts
featured-services-badge

From digital marketing to investor conference support — see how B2i connects what matters.

Explore Our Services

B2i Digital Spotlight

Featured Company

Unicycive Therapeutics, Inc. (Nasdaq: UNCY)

Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead investigational treatment is oxylanthanum carbonate* , a novel phosphate binding agent for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis.

View Company

Featured Conference

Precious Metals & Critical Minerals Hybrid Conference

The Precious Metals & Critical Minerals Virtual Investor Conference brings together public and private companies operating across the precious metals, battery metals, and critical minerals sectors with a global audience of individual and institutional investors for a full day of live virtual presentations.

View Conference